Adlai Nortye Ltd.
NASDAQ:ANLBiotechnology
-$0.11 today
- Market cap
- $463.92M
- Beta
- 0.99
- P/E (TTM)
- -3.0
- EPS (TTM)
- -$3.33
Volume 0.45M
Average 0.35M
ANL EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Adlai Nortye Ltd.NASDAQ: ANL
EBITDA · Q2 FY2024 · quarter ended Jun 2024
EBITDA remains negative
Q2 FY2024 EBITDA was -$14.36M, compared with -$62.58M a year earlier. Trailing-twelve-month EBITDA was -$63.57M.
Context
- EBITDA amounted to 652.5% of revenue in FY2025.
- EBITDA grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 4 analysts of $616.53K (+101.9%) for the fiscal year ending Dec 2026, a step up from the +32.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2024
- -$14.36M+0.0% QoQ
- Last fiscal yearDec 2025
- -$32.63M+32.1% YoY
- LTMJun 2024
- -$63.57M+44.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +77.1% | +100.8% | +23.7 pp |
| 1 year | +32.1% | +101.9% | +69.8 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (32.63M) USD
- Year-over-year change
- +32.1%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (32.63M) | +32.1% |
| FY2024 | 2024-12-31 | (48.06M) | +54.8% |
| FY2023 | 2023-12-31 | (106.22M) | -88.6% |
| FY2022 | 2022-12-31 | (56.32M) | -5.2% |
| FY2021 | 2021-12-31 | (53.51M) | — |
EBITDA vs competitors
How ANL compares with its peers on the latest reported figures
- ANL's LTM Jun 2024 EBITDA of -$63.57M is the 4th highest of the 7 companies compared; the peer median is -$57.4M.
- EBITDA amounts to 979.5% of revenue for ANL, versus a peer median of 108.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $34.88M | +463.6% | — | 48.0% | |
| FY2025 | -$9.22M | +77.5% | — | 108.4% | |
| LTM Mar 2026 | -$42.27M | -2.3% | — | — | |
| LTM Jun 2024 | -$63.57M | — | — | 979.5% | |
| LTM Mar 2026 | -$72.53M | +7.7% | — | 257.0% | |
| LTM Jun 2026 | -$127.04M | +36.8% | — | 74.8% | |
| LTM Mar 2026 | -$191.95M | -32.3% | — | 387.1% | |
| Peer median (excluding ANL) | -$57.4M | +22.3% | — | 108.4% | |
Competitors are the stored peer set for ANL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 45.73M | 0 | 0 | 0 | 5M |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 45.73M | 0 | 0 | 0 | 5M |
| Gross Margin | 100.0% | — | — | — | 100.0% |
| Research & Development | 42.11M | 54.49M | 58.15M | 44.92M | 32.83M |
| Selling, General & Admin | 12.45M | 12.43M | 14.82M | 9.44M | 7.79M |
| Operating Expenses | 54.37M | 67.27M | 72.55M | 52.93M | 40.7M |
| Depreciation & Amortization | 1.83M | 2.04M | 2.22M | 1.87M | 1.41M |
| EBITDA | (53.51M) | (56.32M) | (106.22M) | (48.06M) | (32.63M) |
| EBITDA Margin | -117.0% | — | — | — | -652.5% |
| Operating Income | (8.65M) | (67.27M) | (72.55M) | (52.93M) | (35.7M) |
| Operating Margin | -18.9% | — | — | — | -714.0% |
| Interest Income | 32K | 550K | 62K | 0 | 1K |
| Interest Expense | 1.34M | 433K | 791K | 1.94M | 1.49M |
| Other Income / Expenses | (48.03M) | 8.48M | (36.68M) | 1.06M | 170K |
| Income Before Tax | (56.68M) | (58.79M) | (109.23M) | (51.87M) | (35.53M) |
| Pre-Tax Margin | -124.0% | — | — | — | -710.6% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (56.68M) | (58.79M) | (109.23M) | (51.87M) | (35.53M) |
| Net Margin | -124.0% | — | — | — | -710.6% |
| EPS (Basic) | (6.66) | (6.93) | (15.42) | (4.89) | (3.33) |
| EPS (Diluted) | (6.66) | (6.93) | (15.42) | (4.89) | (3.33) |
| Weighted Avg Shares | 8.48M | 8.48M | 6.8M | 10.64M | 10.66M |
| Weighted Avg Shares (Diluted) | 8.48M | 8.48M | 6.8M | 10.64M | 10.66M |
Adlai Nortye Ltd.
NASDAQ:ANL
Intrinsic Alpha fair value
Locked
Current Price
$8.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.